TipRanks
GE Healthcare Technologies Inc (GEHC)
NASDAQ:GEHC
US Market
GEHC
GE Healthcare Technologies Inc
RESEARCH TOOLSreports
Want to see GEHC full AI Analyst Report?

GE Healthcare Technologies Inc (GEHC) Stock Forecast & Price Target

1,888 Followers
See the Price Targets and Ratings of:

GEHC Analyst Ratings

Moderate Buy
15Ratings
Moderate Buy
10 Buy
5 Hold
0 Sell
Based on 15 analysts giving stock ratings to
GE
Healthcare Technologies Inc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GEHC Stock 12 Month Forecast

Average Price Target

$80.00
▲(9.13% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for GE Healthcare Technologies Inc in the last 3 months. The average price target is $80.00 with a high forecast of $93.00 and a low forecast of $70.00. The average price target represents a 9.13% change from the last price of $73.31.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"59":"$59","94":"$94","67.75":"$67.8","76.5":"$76.5","85.25":"$85.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":93,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$93.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$80.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$70.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[59,67.75,76.5,85.25,94],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.42,72.15692307692308,73.89384615384616,75.63076923076923,77.36769230769231,79.10461538461539,80.84153846153846,82.57846153846154,84.31538461538462,86.05230769230769,87.78923076923077,89.52615384615385,91.26307692307692,{"y":93,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.42,71.15692307692308,71.89384615384616,72.63076923076923,73.36769230769231,74.10461538461539,74.84153846153846,75.57846153846154,76.31538461538462,77.05230769230769,77.78923076923077,78.52615384615385,79.26307692307692,{"y":80,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.42,70.3876923076923,70.35538461538462,70.32307692307693,70.29076923076923,70.25846153846155,70.22615384615385,70.19384615384615,70.16153846153846,70.12923076923077,70.09692307692308,70.06461538461538,70.0323076923077,{"y":70,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":73.589,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.366,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.841,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.125,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.901,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.025,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.075,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.904,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.995,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.654,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.823,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.02,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.42,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$93.00Average Price Target$80.00Lowest Price Target$70.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Needham Analyst forecast on GEHC
David Saxon
Needham
Needham
$93
Buy
26.86%
Upside
Initiated
09/22/26
GE HealthCare initiated with a Buy at NeedhamGE HealthCare initiated with a Buy at Needham
Bank of America Securities Analyst forecast on GEHC
Travis Steed
Bank of America Securities
Bank of America Securities
$74
Hold
0.94%
Upside
Reiterated
09/14/26
GE Healthcare Hold Rating Maintained as Analyst Weighs Sofie Acquisition Risks; $74 Price Target Unchanged
BMO Capital Analyst forecast on GEHC
Vik Chopra
BMO Capital
BMO Capital
$71
Hold
-3.15%
Downside
Reiterated
09/13/26
GE Healthcare Kept at Hold as Analyst Weighs Sofie Deal Upside Against Execution Risks; $71 Price Target Reiterated
Wells Fargo Analyst forecast on GEHC
Larry Biegelsen
Wells Fargo
Wells Fargo
$85
Buy
15.95%
Upside
Assigned
08/25/26
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Biogen (NASDAQ: BIIB) and BeOne Medicines (NASDAQ: ONC)
BTIG Analyst forecast on GEHC
Ryan Zimmerman
BTIG
BTIG
$79
Buy
7.76%
Upside
Reiterated
08/19/26
Analysts Are Bullish on These Healthcare Stocks: Tvardi Therapeutics (TVRD), GE Healthcare Technologies Inc (GEHC)
Citi Analyst forecast on GEHC
Joanne Wuensch
Citi
Citi
$75
Hold
2.31%
Upside
Reiterated
08/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Liquidia Technologies (NASDAQ: LQDA) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Mizuho Securities Analyst forecast on GEHC
Anthony Petrone
Mizuho Securities
Mizuho Securities
$85
Buy
15.95%
Upside
Reiterated
07/31/26
GE Healthcare Technologies Inc (GEHC) Gets a Buy from Mizuho Securities
UBS Analyst forecast on GEHC
Graham Doyle
UBS
UBS
$67→$73
Hold
-0.42%
Downside
Assigned
07/31/26
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Bristol-Myers Squibb (NYSE: BMY) and Stryker (NYSE: SYK)
Jefferies Analyst forecast on GEHC
Matthew Taylor
Jefferies
Jefferies
$90→$92
Buy
25.49%
Upside
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: Omnicell (NASDAQ: OMCL), Daiichi Sankyo Company (Other OTC: DSKYF) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Oppenheimer Analyst forecast on GEHC
Suraj Kalia
Oppenheimer
Oppenheimer
$85
Buy
15.95%
Upside
Reiterated
07/30/26
GE Healthcare Technologies Inc (GEHC) Receives a Buy from Oppenheimer
J.P. Morgan Analyst forecast on GEHC
Robbie Marcus
J.P. Morgan
J.P. Morgan
$65→$70
Hold
-4.52%
Downside
Assigned
07/30/26
GE HealthCare price target raised to $70 from $65 at JPMorganGE HealthCare price target raised to $70 from $65 at JPMorgan
Evercore ISI Analyst forecast on GEHC
Vijay Kumar
Evercore ISI
Evercore ISI
$80→$84
Buy
14.58%
Upside
Reiterated
07/30/26
GE HealthCare price target raised to $84 from $80 at Evercore ISIGE HealthCare price target raised to $84 from $80 at Evercore ISI
Stifel Nicolaus Analyst forecast on GEHC
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$80
Buy
9.13%
Upside
Reiterated
07/30/26
Stifel Nicolaus Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC)
RBC Capital Analyst forecast on GEHC
Kendall Au
RBC Capital
RBC Capital
$80
Buy
9.13%
Upside
Reiterated
07/29/26
RBC Capital Sticks to Their Buy Rating for GE Healthcare Technologies Inc (GEHC)
Piper Sandler Analyst forecast on GEHC
Jason Bednar
Piper Sandler
Piper Sandler
$74
Buy
0.94%
Upside
Reiterated
07/24/26
Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Edwards Lifesciences (EW)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Needham Analyst forecast on GEHC
David Saxon
Needham
Needham
$93
Buy
26.86%
Upside
Initiated
09/22/26
GE HealthCare initiated with a Buy at NeedhamGE HealthCare initiated with a Buy at Needham
Bank of America Securities Analyst forecast on GEHC
Travis Steed
Bank of America Securities
Bank of America Securities
$74
Hold
0.94%
Upside
Reiterated
09/14/26
GE Healthcare Hold Rating Maintained as Analyst Weighs Sofie Acquisition Risks; $74 Price Target Unchanged
BMO Capital Analyst forecast on GEHC
Vik Chopra
BMO Capital
BMO Capital
$71
Hold
-3.15%
Downside
Reiterated
09/13/26
GE Healthcare Kept at Hold as Analyst Weighs Sofie Deal Upside Against Execution Risks; $71 Price Target Reiterated
Wells Fargo Analyst forecast on GEHC
Larry Biegelsen
Wells Fargo
Wells Fargo
$85
Buy
15.95%
Upside
Assigned
08/25/26
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Biogen (NASDAQ: BIIB) and BeOne Medicines (NASDAQ: ONC)
BTIG Analyst forecast on GEHC
Ryan Zimmerman
BTIG
BTIG
$79
Buy
7.76%
Upside
Reiterated
08/19/26
Analysts Are Bullish on These Healthcare Stocks: Tvardi Therapeutics (TVRD), GE Healthcare Technologies Inc (GEHC)
Citi Analyst forecast on GEHC
Joanne Wuensch
Citi
Citi
$75
Hold
2.31%
Upside
Reiterated
08/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Liquidia Technologies (NASDAQ: LQDA) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Mizuho Securities Analyst forecast on GEHC
Anthony Petrone
Mizuho Securities
Mizuho Securities
$85
Buy
15.95%
Upside
Reiterated
07/31/26
GE Healthcare Technologies Inc (GEHC) Gets a Buy from Mizuho Securities
UBS Analyst forecast on GEHC
Graham Doyle
UBS
UBS
$67→$73
Hold
-0.42%
Downside
Assigned
07/31/26
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Bristol-Myers Squibb (NYSE: BMY) and Stryker (NYSE: SYK)
Jefferies Analyst forecast on GEHC
Matthew Taylor
Jefferies
Jefferies
$90→$92
Buy
25.49%
Upside
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: Omnicell (NASDAQ: OMCL), Daiichi Sankyo Company (Other OTC: DSKYF) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Oppenheimer Analyst forecast on GEHC
Suraj Kalia
Oppenheimer
Oppenheimer
$85
Buy
15.95%
Upside
Reiterated
07/30/26
GE Healthcare Technologies Inc (GEHC) Receives a Buy from Oppenheimer
J.P. Morgan Analyst forecast on GEHC
Robbie Marcus
J.P. Morgan
J.P. Morgan
$65→$70
Hold
-4.52%
Downside
Assigned
07/30/26
GE HealthCare price target raised to $70 from $65 at JPMorganGE HealthCare price target raised to $70 from $65 at JPMorgan
Evercore ISI Analyst forecast on GEHC
Vijay Kumar
Evercore ISI
Evercore ISI
$80→$84
Buy
14.58%
Upside
Reiterated
07/30/26
GE HealthCare price target raised to $84 from $80 at Evercore ISIGE HealthCare price target raised to $84 from $80 at Evercore ISI
Stifel Nicolaus Analyst forecast on GEHC
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$80
Buy
9.13%
Upside
Reiterated
07/30/26
Stifel Nicolaus Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC)
RBC Capital Analyst forecast on GEHC
Kendall Au
RBC Capital
RBC Capital
$80
Buy
9.13%
Upside
Reiterated
07/29/26
RBC Capital Sticks to Their Buy Rating for GE Healthcare Technologies Inc (GEHC)
Piper Sandler Analyst forecast on GEHC
Jason Bednar
Piper Sandler
Piper Sandler
$74
Buy
0.94%
Upside
Reiterated
07/24/26
Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Edwards Lifesciences (EW)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OCULOcular Therapeutix
GHGuardant Health
HROWHarrow Health
DNLIDenali Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GE Healthcare Technologies Inc

3 Months
Jason BednarPiper Sandler
Success Rate
8/14 ratings generated profit
57%
Average Return
+0.41%
Copying Jason Bednar's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +0.41% per trade.
1 Year
Anthony PetroneMizuho Securities
Success Rate
6/16 ratings generated profit
38%
Average Return
-0.98%
Copying Anthony Petrone's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -0.98% per trade.
2 Years
Larry BiegelsenWells Fargo
Success Rate
7/23 ratings generated profit
30%
Average Return
-9.30%
Copying Larry Biegelsen's trades and holding each position for 2 Years would result in 30.43% of your transactions generating a profit, with an average return of -9.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GEHC Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
14
13
20
22
21
Hold
9
7
10
11
12
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
20
30
33
33
In the current month, GEHC has received 21 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. GEHC average Analyst price target in the past 3 months is 80.00.
Each month's total comprises the sum of three months' worth of ratings.

GEHC Financial Forecast

GEHC Earnings Forecast

Next quarter’s earnings estimate for GEHC is $1.20 with a range of $1.18 to $1.25. The previous quarter’s EPS was $1.13. GEHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.
Next quarter’s earnings estimate for GEHC is $1.20 with a range of $1.18 to $1.25. The previous quarter’s EPS was $1.13. GEHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.

GEHC Sales Forecast

Next quarter’s sales forecast for GEHC is $5.35B with a range of $5.28B to $5.43B. The previous quarter’s sales results were $5.29B. GEHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.
Next quarter’s sales forecast for GEHC is $5.35B with a range of $5.28B to $5.43B. The previous quarter’s sales results were $5.29B. GEHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.

GEHC Stock Forecast FAQ

What is GEHC’s average 12-month price target, according to analysts?
Based on analyst ratings, GE Healthcare Technologies Inc’s 12-month average price target is 80.00.
    What is GEHC’s upside potential, based on the analysts’ average price target?
    GE Healthcare Technologies Inc has 9.13% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GEHC a Buy, Sell or Hold?
          GE Healthcare Technologies Inc has a consensus rating of Moderate Buy which is based on 10 buy ratings, 5 hold ratings and 0 sell ratings.
            What is GE Healthcare Technologies Inc’s price target?
            The average price target for GE Healthcare Technologies Inc is 80.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $93.00 ,the lowest forecast is $70.00. The average price target represents 9.13% Increase from the current price of $73.31.
              What do analysts say about GE Healthcare Technologies Inc?
              GE Healthcare Technologies Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of GEHC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.